Defibrillation is a treatment for life-threatening cardiac dysrhythmias, specifically ventricular fibrillation (VF) and non-perfusing ventricular tachycardia (VT).

The global Defibrillator Devices market was valued at 9990 million US$ in 2018 and will reach 14300 million US$ by the end of 2025, growing at a CAGR of 4.6% during 2019-2025.
This report focuses on Defibrillator Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Defibrillator Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Defibrillator Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Defibrillator Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Medtronic
Abbott
Boston Scientific
BIOTRONIK
LivaNova
Stryker
Philips
Cardiac Science
Zoll Medical
Nihon Kohden
Progetti
Fukuda Denshi
Schiller

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Implantable Devices
External Devices

Segment by Application
Hospitals
Ambulatory Surgery Centre
Others